-
Mashup Score: 2Active cancer increases death risk in patients with COVID-19 - 4 year(s) ago
Cancer in progression and treatment with hydroxychloroquine plus azithromycin were associated with an increased risk of death in cancer patients with COVID-19.
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Active cancer increases death risk in patients with COVID-19 - 4 year(s) ago
Cancer in progression and treatment with hydroxychloroquine plus azithromycin were associated with an increased risk of death in cancer patients with COVID-19.
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Active cancer increases death risk in patients with COVID-19 - 4 year(s) ago
Cancer in progression and treatment with hydroxychloroquine plus azithromycin were associated with an increased risk of death in cancer patients with COVID-19.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Active cancer increases death risk in patients with COVID-19 - 4 year(s) ago
Cancer in progression and treatment with hydroxychloroquine plus azithromycin were associated with an increased risk of death in cancer patients with COVID-19.
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
Dr. Erika Hamilton explores the culture of blame around cancer, in which patients are shamed for failing to prevent cancer and judged on all of the decisions they make.
Source: ASCO ConnectionCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 17Learn | Young Survival Coalition - 4 year(s) ago
Learn Young women can and do get breast cancer. We believe that knowledge and understanding can make us all stronger. We hope these pages help you learn about breast cancer at your own pace—so you can feel more confident and in control of your…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 7Making Cancer Clinical Trials Available to More Patients - 4 year(s) ago
NCI is expanding eligibility criteria for cancer clinical trials in the hope that more patients will join trials, leading to more rapid advances in cancer care.
Source: National Cancer InstituteCategories: Hem/Oncs, Latest HeadlinesTweet
Active cancer increases death risk in patients with COVID-19. #ASCO20 @ASCO https://t.co/X3EAFV0NyG #Oncoalert #ListenUpMBC #COVID19 #ASCO2020 https://t.co/WXX6giXLfR